Skip to main content
    U

    USANA Health Sciences Inc (USNA)

    Official site

    CONSUMER DEFENSIVE • PACKAGED FOODS • NYSE

    $13.55
    +0.31 (+2.34%)

    Market Cap: $244.79M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    USANA Health Sciences Inc (USNA) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    USANA Health Sciences (USNA) is expected to report earnings on Feb 10, 2027. In the quarter ended Sep 30, 2026, USANA Health Sciences reported EPS of -$0.11, below the $0.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    68%(27/40)
    Avg Surprise
    +7.93%

    Upcoming Estimates

    Reports Feb 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.12
    Range$0.12 - $0.13
    3 analysts
    Revenue Consensus
    $224.10M
    Range$215.31M - $230.69M
    3 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.24
    Range$0.24 - $0.24
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.34-29.4%
    60d ago$0.34-29.4%
    30d ago$0.34-29.4%
    7d ago$0.34-29.4%
    Current$0.24
    Revenue Consensus
    $245.80M
    Range$245.80M - $245.80M
    1 analysts

    Next Report

    USNA has an expected report date of Feb 10, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 80.0% below the $0.60 reported for the quarter ended Dec 31, 2025.

    USNA Earnings Call

    The latest USNA earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, USNA beat 27, missed 12 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $205.88M, down 3.6% from $213.67M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.11$0.11$0.11 - $0.11-200.00%MissN/A10 up, 1 downNov 3, 2026$205.88M
    Jun 30, 2026-$0.07$0.43$0.43 - $0.43-116.28%Miss-109.5%10 up, 1 downAug 4, 2026$223.27M
    Mar 31, 2026$0.61$0.44$0.44 - $0.44+38.64%Beat-16.4%11 up, 0 downMay 5, 2026$250.22M
    Dec 31, 2025$0.60$0.41$0.41 - $0.41+46.34%Beat-6.3%11 up, 0 downFeb 17, 2026$226.20M
    Sep 30, 2025-$0.15-$0.15-$0.15 - -$0.150.00%In line-126.8%10 up, 1 downOct 21, 2025$213.67M
    Jun 30, 2025$0.74$0.54$0.54 - $0.54+37.04%Beat+37.0%10 up, 1 downJul 22, 2025$235.85M
    Mar 31, 2025$0.73$0.70$0.70 - $0.70+4.29%Beat-15.1%10 up, 1 downApr 22, 2025$249.54M
    Dec 31, 2024$0.64$0.49$0.49 - $0.49+30.61%Beat-26.4%20 up, 1 downFeb 25, 2025$213.61M
    Sep 30, 2024$0.56$0.49$0.46 - $0.51+14.29%Beat-5.1%20 up, 0 downOct 22, 2024$200.22M
    Jun 30, 2024$0.54$0.65$0.62 - $0.68-16.92%Miss-39.3%20 up, 0 downJul 23, 2024$212.87M
    Mar 31, 2024$0.86$0.69$0.63 - $0.75+24.64%Beat-9.5%20 up, 0 downApr 30, 2024$227.80M
    Dec 31, 2023$0.87$0.52$0.50 - $0.53+67.31%Beat+31.8%20 up, 0 downFeb 6, 2024$221.08M
    Sep 30, 2023$0.59$0.64$0.60 - $0.67-7.81%Miss-24.4%20 up, 0 downOct 24, 2023$213.37M
    Jun 30, 2023$0.89$0.70$0.62 - $0.77+27.14%Beat-11.0%20 up, 0 downJul 25, 2023$238.20M
    Mar 31, 2023$0.95$0.77$0.77 - $0.77+23.38%Beat-17.4%10 up, 0 downApr 25, 2023$248.36M
    Dec 31, 2022$0.66$0.35$0.35 - $0.35+88.57%Beat-35.9%10 up, 0 downFeb 7, 2023$227.96M
    Sep 30, 2022$0.78$0.89$0.89 - $0.89-12.36%Miss-42.6%10 up, 0 downOct 25, 2022$233.30M
    Jun 30, 2022$1.00$1.05$1.05 - $1.30-4.76%Miss-46.5%30 up, 1 downJul 26, 2022$264.47M
    Mar 31, 2022$1.15$1.14$1.13 - $1.15+0.88%Beat-20.7%30 up, 0 downApr 26, 2022$272.87M
    Dec 31, 2021$1.03$1.28$1.26 - $1.30-19.53%Miss-44.9%2N/AFeb 8, 2022$267.30M
    Sep 30, 2021$1.36$1.35N/A+0.74%Beat-5.6%20 up, 0 downOct 26, 2021$274.35M
    Jun 30, 2021$1.87$1.78$1.65 - $1.78+5.06%Beat+41.7%2N/AJul 27, 2021$336.84M
    Mar 31, 2021$1.45$1.57$1.40 - $1.57-7.64%Miss+17.9%2N/AApr 27, 2021$307.98M
    Dec 31, 2020$1.87$1.39$1.31 - $1.51+34.53%Beat+32.6%3N/AFeb 9, 2021$310.52M
    Sep 30, 2020$1.44$1.29N/A+11.63%Beat+32.1%2N/AOct 20, 2020$298.51M
    Jun 30, 2020$1.32$1.19$0.97 - $1.19+10.92%Beat+45.1%2N/AJul 21, 2020$258.99M
    Mar 31, 2020$1.23$0.57$0.57 - $1.10+115.79%Beat+21.8%2N/AApr 21, 2020$266.62M
    Dec 31, 2019$1.41$0.98$0.98 - $0.99+43.88%Beat+6.8%2N/AFeb 4, 2020$271.30M
    Sep 30, 2019$1.09$0.87$0.84 - $0.90+25.29%Beat-12.1%3N/AOct 22, 2019$260.60M
    Jun 30, 2019$0.91$0.93$0.91 - $0.94-2.15%Miss-33.1%3N/AJul 23, 2019$256.02M
    Mar 31, 2019$1.01$0.99$0.98 - $1.00+2.02%Beat-15.1%3N/AApr 30, 2019$272.99M
    Dec 31, 2018$1.32$1.29$1.22 - $1.41+2.33%Beat+18.9%3N/AFeb 5, 2019$299.02M
    Sep 30, 2018$1.24$1.10$1.04 - $1.16+12.73%Beat+21.6%3N/AOct 23, 2018$296.77M
    Jun 30, 2018$1.36$1.11$1.10 - $1.16+22.52%Beat+38.8%2N/AJul 24, 2018$301.46M
    Mar 31, 2018$1.19$1.05$1.03 - $1.10+13.33%Beat+38.4%3N/AApr 24, 2018$292.00M
    Dec 31, 2017$1.11$1.00$0.97 - $1.03+11.00%Beat+27.6%3N/AFeb 6, 2018$273.11M
    Sep 30, 2017$1.02$0.91$0.85 - $0.96+12.09%Beat-15.0%2N/AOct 24, 2017$261.76M
    Jun 30, 2017$0.98$1.06$1.05 - $1.24-7.55%Miss-4.9%2N/AJul 25, 2017$257.06M
    Mar 31, 2017$0.86$0.92N/A-6.52%Miss-3.4%N/AN/AMay 2, 2017$255.32M
    Dec 31, 2016$0.87$0.95N/A-8.42%Miss-5.4%N/AN/AFeb 7, 2017$252.90M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $1.92, down 26.2% from the year before. It was $3.99 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$1.92-26.2%
    Dec 31, 2024$2.60-21.2%
    Dec 31, 2023$3.30-8.1%
    Dec 31, 2022$3.59-37.1%
    Dec 31, 2021$5.71-2.6%
    Dec 31, 2020$5.86+32.6%
    Dec 31, 2019$4.42-13.5%
    Dec 31, 2018$5.11+28.7%
    Dec 31, 2017$3.97N/A
    Dec 31, 2016$3.99N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,400 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20263,4408
    2026Q2Jun 30, 20264,40410
    2026Q1Mar 31, 20263,5879
    2025Q4Dec 31, 20253,6099
    2025Q3Sep 30, 20253,99610
    2025Q2Jun 30, 20253,9258
    2025Q1Mar 31, 20252,6378
    2024Q4Dec 31, 20243,63110

    2026Q3 Earnings Call

    Opening remarks

    Andrew Masuda Director of Investor Relations Thank you, and good morning, everyone. We appreciate you joining us to review our third quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ materially from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2026, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC. During today's call, we will also refer to certain non-GAAP financial measures, including adjusted EBITDA and free cash flow. Reconciliations of these measures to the most directly comparable GAAP measures are included in our earnings release. I'm joined by our Chairman and Chief Executive Officer, Kevin Guest; our Chief Financial Officer, Doug Hekking; our Chief Commercial Officer, Brent Neidig; our Chief Operating Officer, Walter Noot; our Chief Scientific Officer, Dr. Kathryn Armstrong; and other executives. Yesterday, after the market closed, we announced our third quarter results and posted our management commentary document on the company's website. We'll now hear brief remarks from Kevin and Doug before opening the call for questions.

    Kevin Guest Chairman and Chief Executive Officer Thank you, Andrew, and good morning, everyone. I'd like to speak to the strategy we're executing, where we're seeing progress, and where we still have work to do. Our earnings release and management commentary present the numbers for the business. So I'll focus on providing context for the numbers and then ask Doug to add more color on how our strategy is coming to fruition. Overall, this was a mixed quarter, but one where I'm encouraged by the progress we're seeing with our strategy. Our strategy is to evolve USANA from a single-channel direct-selling company into a diversified omnichannel health and wellness company built on consumer acquisition and loyalty. In Core Nutrition, we're working to increase customer acquisition and customer loyalty by investing in the USANA brand, bringing new products to market, and further refining our incentive structure. Through Hiya and Rise Wellness, we're expanding our business to reach consumers at more venues where they already shop, including retail and Amazon. Our debt-free balance sheet lets us fund this expansion with discipline. Let me start with what's working.

    Frequently Asked Questions About USNA

    When is USANA Health Sciences's next earnings date?

    USANA Health Sciences's next earnings report is expected for Feb 10, 2027.

    Did USNA beat earnings estimates last quarter?

    No. USANA Health Sciences reported EPS of -$0.11 for the quarter ended Sep 30, 2026, below the $0.11 estimate by 200.00%.

    What EPS do analysts expect from USNA next quarter?

    The consensus EPS estimate for USANA Health Sciences for the quarter ending Dec 31, 2026 is $0.12 from 3 analysts, with estimates from $0.12 to $0.13.

    How often does USNA beat earnings estimates?

    USANA Health Sciences beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -19.92%.